Textbook Of Complex General Surgical Oncology
Speaking of SurgOnc is a podcast brought to you by the Annals of Surgical Oncology (ASO) and the Society of Surgical Oncology (SSO). The series is hosted by ASO Deputy Editor Dr. Frederick L. (Rick) Greene, who expands upon ideas from articles published in the Annals of Surgical Oncology. Once a month, Dr. Greene interviews authors and leading experts in surgical oncology.
Textbook Of Complex General Surgical Oncology
As one of several modalities in the management of cancer, the specialty of surgical oncology has evolved in steps similar to medical oncology (pharmacotherapy for cancer), which grew out of hematology, and radiation oncology, which grew out of radiology. The Ewing Society known today as the Society of Surgical Oncology was started by surgeons interested in promoting the field of oncology. Complex General Surgical Oncology was ratified by a specialty Board certification in 2011 from the American Board of Surgery. The proliferation of cancer centers will continue to popularize the field, as will developments in minimally invasive techniques, palliative surgery, and neo-adjuvant treatments.
Whether surgical oncology constitutes a medical specialty per se is the topic of a heated debate. Today, some would agree that it is simply impossible for any one surgeon to be competent in the surgical management of all malignant disease There are currently 19 surgical oncology fellowship training programs in the United States that have been approved by the Society of Surgical Oncology and this number is expect to grow. While many general surgeons are actively involved in treating patients with malignant neoplasms, the designation of "surgical oncologist" is generally reserved for those surgeons who have completed one of the approved fellowship programs. However, this is a matter of semantics, as many surgeons who are thoroughly involved in treating cancer patients may consider themselves to be surgical oncologists.
Most often, surgical oncologist refers to a general surgical oncologist (a subspecialty of general surgery), but thoracic surgical oncologists, gynecologic oncologists and so forth can all be considered surgeons who specialize in treating cancer patients.
One of the first text books dedicated to surgical oncology was written by the American-Irish surgeon, Dr. Theodore O'Connell in 1981. Many publications in surgical oncology are also appearing. The majority are large reference textbooks that seemingly combine specialties that are not generally practiced by a single practitioner but cover the academic subject. A number of practical handbooks such as "surgical oncology" in the well read Oxford Handbooks series, have recently been published, perhaps alluding to the evolving practicality of this emerging discipline.
Dr. Amanda Kirane is a fellowship-trained, board-certified specialist in complex general surgical oncology. She is an assistant professor in the Department of Surgery, Section of Surgical Oncology, at Stanford University School of Medicine.
Dr. Kim is a recognized expert in surgical diseases of the endocrine glands. He has written on a variety of topics related to these conditions (see below). He is co-editor of a major textbook on thyroid cancer published in 2017. He has served as Program Chair of the annual meeting of the American Association of Endocrine Surgeons. He is currently Chair of the Endocrine Disease Site Workgroup for the Society of Surgical Oncology. He has been an invited speaker at national and international organizations including the American Association of Clinical Endocrinologists and the International Association of Endocrine Surgeons. He is particularly recognized in the use of office-based ultrasound for endocrine diseases and teaches ultrasound at national and international courses. He was recently elected to the Complex General Surgical Oncology Board of the American Board of Surgery, representing the American Association of Endocrine Surgeons.
Dr. Kirane is a fellowship-trained, board-certified specialist in complex general surgical oncology. She is an assistant professor in the Department of Surgery, Section of Surgical Oncology, at Stanford University School of Medicine.Her clinical practice focuses on the diagnosis and treatment of melanoma and other skin cancers. She partners closely with patients and families to provide the most effective treatment approach possible. For each patient, she tailors an evidence-based, personalized care plan that is innovative, comprehensive, and compassionate. Dr. Kirane has conducted extensive research and been the principal investigator of multiple studies in melanoma and associated malignancies. Her current interests include immune response and novel therapies in melanoma. She has led research into immune therapy for melanoma that is resistant to current standards of care. The National Institutes of Health, American Society of Clinical Oncology, and others have funded her research. She has co-authored articles on her discoveries in the Journal of Dermatological Treatment, Journal of Surgical Oncology, Journal of Surgical Research, Annals of Surgery, and elsewhere. Topics include advances in non-surgical management of melanoma.She also co-wrote the chapter on the management of soft tissue sarcoma in the textbook Current Surgical Therapy.Dr. Kirane has presented updates on the management of melanoma and other cancers to her peers at meetings of the American College of Surgeons, Society of Surgical Oncology, and Society for Immunotherapy in Cancer.She has earned awards for her achievements in clinical care, research, and scholarship. The Society for Immunotherapy of Cancer, Society of Surgical Oncology, Memorial Sloan Kettering Cancer Center, and other prestigious organizations have honored her work.Dr. Kirane is a fellow of the American College of Surgeons (FACS) and Society of Surgical Oncology (FSSO). She is a member of the Society for Immunotherapy of Cancer, American Association of Cancer Research, Society for Melanoma Research, Connective Tissue Oncology Society, Association of Academic Surgeons, and Association of Women Surgeons.She volunteers her time and expertise on behalf of the Melanoma Research Foundation, members of her community in need, STEM programs for girls, and other initiatives. She is also a Pilates instructor.
Dr. Eugene Kim is Professor of Surgery and Pediatrics, Division of Pediatric Surgery and Division of Hematology, Oncology, Blood and Marrow Transplantation at the University of Southern California Keck School of Medicine in Los Angeles, California. Dr. Kim has clinical expertise in pediatric surgical oncology, the management of chest wall deformities and anorectal malformations. Dr. Kim is the principal investigator of a basic science laboratory focused on novel preclinical therapeutics for the aggressive childhood malignancy, neuroblastoma. His research interests are focused on the mechanisms and pathways responsible for recurrent metastatic disease, the primary cause of death in children with high-risk neuroblastoma.
Dr. Wayne Shannon Orr III, a UMMC graduate and recent complex general surgical oncology fellow at the M.D. Anderson Cancer Center, has joined the Medical Center faculty as an assistant professor of surgery.
After receiving his B.S. in chemistry from Delta State University in 2000, Orr earned his M.D. at UMMC in 2006. He had a general surgery residency at the University of Tennessee Health Science Center-Memphis from 2006-13, a research fellowship at St. Jude Children's Research Hospital, Memphis, from 2009-11 and a complex general surgical oncology fellowship at the M.D. Anderson Cancer Center, Houston, Texas, from 2013-15.
The Department of Surgery at ECU HEALTH is seeking a dynamic, academically oriented surgical oncologist at the rank/title of Associate Professor or Professor to lead the division of surgical oncology at ECU Health Medical Center and the ECU Brody School of Medicine.The successful candidate will lead an active, collaborative clinical, teaching and research program consisting of three surgical oncologists, two colorectal surgeons and one breast surgeon. The ideal candidate would have an established record of academic productivity, a national presence, leadership experience in a matrixed health care environment, and a broad knowledge in all aspects of complex general surgical oncology including GI, HPB, melanoma, breast and sarcoma.Additional leadership opportunities exist for qualified individuals within the department, hospital and cancer service line.Highlights:Academic employmentWell established multidisciplinary ACS-COC accredited cancer program with identified disease specialists in all areas of oncology including breast oncology
NAPBC accredited breast cancer program
Three DaVinci Xi Robots with teaching console
Outpatient surgery center
Fixed term or Tenure track faculty position
Dedicated 500,000 square foot freestanding cancer hospital opened in 2018 and equipped with a state-of-the-art radiation oncology center, dedicated breast imaging center, multi-disciplinary oncology clinic as well as 24 surgical oncology in-patient beds.
4 linear accelerators including cyberknife, gammaknife, SBRT, HDR and plans for the addition of an MR Linac.
Hospital privileges at Vidant Medical Center, a 974-bed level 1 trauma center